Developing an IUD Inserter for Postpartum Women

The story below originally appeared on USAID’s blog.  Dr. Sharad Singh from Population Services International (PSI) recalls the story of a new young mother, Sarita.* “She held her newborn daughter and promised her the best of everything. This silent conversation was suddenly interrupted by the image of her neighborhood friend who had three children in

Read More

Innovation Challenge Grant Winner Reports Successful Pilot Study for New Contraceptive Procedure

Using a new cheaper, simpler inserter for IUDs after labor and delivery can save lives in the developing  world. Washington, DC, (March 22, 2016) Following a proof-of-concept study to be published March 23 in the journal Global Health Science and Practice, Population Services International (PSI) Global Medical Director Paul Blumenthal, MD, reports benefits from a

Read More

PSI is a Saving Lives at Birth Grand Challenge Finalist

IMG_1050PSI is proud to join 22 Round 3 award nominees from a pool of 53 finalists in the Saving Lives at Birth: A Grand Challenge for Development. Our Immediate postpartum intrauterine device (PPIUD) insertion study was listed alongside 17 grant seed nominees yesterday afternoon. Dr. Jyoti Vajpayee, Senior Technical Advisor, and Dr. Paul Blumenthal, professor of obstetrics and gynecology and director of the Stanford Program for International Reproductive Education and Services, (pictured to the left) were on hand to receive the award.

The award nominees cut across maternal and neonatal health, family planning, nutrition and HIV and they present not only cutting-edge technologies that can be used in resource-poor settings, but innovative approaches to delivering services and the adoption of healthy behaviors. The announcement was made at the closing forum of the DevelopmentXChange by the Saving Lives at Birth partners. The nominees will now enter into final negotiations before awards are issued.

The primary objective of the study is to determine the safety, acceptability (provider/consumer comfort and confidence), feasibility, and efficacy of PPIUD inserters. The expected impact of the project is validation to take this technology to scale and to increase uptake of long-acting reversible contraceptives globally. The innovation in this project is a significant improvement over the standard practice because the validation of a new prototype for a dedicated PPIUD inserter will dramatically improve service delivery and increase uptake of PPIUDs.

Dr Blumenthal recently spoke with the Stanford School of Medicine on how his work with PSI has helped identify ways to increase IUD use in developing countries.

Project director Dana Tilson added, “When contraceptives are available in these settings, they are often limited to one or two options, all requiring frequent, repeat visits to continue.”

In an effort to, in Tilson’s words, “give women access to a range of choices that were previously unavailable” and to improve reproductive health, the researchers launched a two-year, 13-country initiative to promote and provide IUDs.


Read More